Literature DB >> 26297547

miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.

Hong Lan1, Wangsheng Chen2, Guoli He1, Shuying Yang1.   

Abstract

Dysregulation of miRNAs is a common feature in human cancers, and miR-140-5p has been found to be down-regulated in cancer. However its role in ovarian cancer remains unclear. miR-140-5p was underexpressed in HCC tissues and cell lines compared with their normal controls. Additionally, PDGFRA was predicted the target gene of miR-140-5p. PDGFRA was inversely correlated with the expression of miR-140-5p in ovarian cancer cells. Importantly, we demonstrate that the over expression of miR-140-5p significantly inhibits ovarian cancer cell proliferation and induces apoptosis. Our results suggest the existence of a novel miR-140-5p-PDGFRA pathway and indicate that miR-140-5p acts as a tumor suppressor during ovarian carcinogenesis. These results may provide a promising alterative strategy for the therapeutic treatment of ovarian cancer.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Ovarian cancer; PDGFRA; miR-140-5p

Mesh:

Substances:

Year:  2015        PMID: 26297547     DOI: 10.1016/j.biopha.2015.07.035

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  33 in total

Review 1.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

2.  Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.

Authors:  Lei Sun; Peng Sun; Qi-Ying Zhou; Xiangchun Gao; Qing Han
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

Review 3.  Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story.

Authors:  Ekati Drakopoulou; Nicholas P Anagnou; Kalliopi I Pappa
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

4.  LINC01534 Promotes the Aberrant Metabolic Dysfunction and Inflammation in IL-1β-Simulated Osteoarthritic Chondrocytes by Targeting miR-140-5p.

Authors:  Wei Wei; Shaoxuan He; Zhihua Wang; Junjie Dong; Dong Xiang; Yunxuan Li; Lirong Ren; Nannan Kou; Jia Lv
Journal:  Cartilage       Date:  2019-11-16       Impact factor: 3.117

5.  MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer.

Authors:  Bofan Yu; Wei You; Guang Chen; Yang Yu; Qinheng Yang
Journal:  Cell Cycle       Date:  2019-08-14       Impact factor: 5.173

6.  Prediction of target genes for miR-140-5p in pulmonary arterial hypertension using bioinformatics methods.

Authors:  Fangwei Li; Wenhua Shi; Yixin Wan; Qingting Wang; Wei Feng; Xin Yan; Jian Wang; Limin Chai; Qianqian Zhang; Manxiang Li
Journal:  FEBS Open Bio       Date:  2017-10-21       Impact factor: 2.693

7.  MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy.

Authors:  Yichen Meng; Rui Gao; Jun Ma; Jianquan Zhao; Enjie Xu; Ce Wang; Xuhui Zhou
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

8.  MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.

Authors:  Maskomani Silambarasan; Jun Rong Tan; Dwi Setyowati Karolina; Arunmozhiarasi Armugam; Charanjit Kaur; Kandiah Jeyaseelan
Journal:  Int J Mol Sci       Date:  2016-04-07       Impact factor: 5.923

9.  Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein.

Authors:  Xiaoguang Li; Qian Ba; Yanling Liu; Qingxi Yue; Peizhan Chen; Jingquan Li; Haibing Zhang; Hao Ying; Qiurong Ding; Haiyun Song; Hong Liu; Ruiwen Zhang; Hui Wang
Journal:  Cell Discov       Date:  2017-11-21       Impact factor: 10.849

Review 10.  Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation.

Authors:  Shunsuke Kitajima; Chiaki Takahashi
Journal:  Cancer Sci       Date:  2017-07-29       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.